共 70 条
[1]
Bannon MJ(2005)The dopamine transporter: role in neurotoxicity and human disease Toxicol Appl Pharmacol 204 355-360
[2]
Vaughan RA(2013)Mechanisms of dopamine transporter regulation in normal and disease states Trends Pharmacol Sci 34 489-496
[3]
Foster JD(2017)Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers Mov Disord 32 181-192
[4]
Strafella AP(2009)Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria Lancet Neurol 8 1150-1157
[5]
Bohnen NI(2014)Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials BMJ Open 4 1397-1406
[6]
Perlmutter JS(2007)Quantification of dopamine transporter binding using 18FFP-beta-CIT and positron emission tomography J Cereb Blood Flow Metab 27 1065-1073
[7]
Dickson DW(2012)Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I J Nucl Med 53 217-222
[8]
Braak H(2014)Quantification of dopamine transporter density with 18FFECNT PET in healthy humans Nucl Med Biol 41 1521-1530
[9]
Duda JE(1998)Dopamine transporter imaging with fluorine-18-FPCIT and PET J Nucl Med 39 90-1487
[10]
O'Brien JT(2019)The story of the dopamine transporter PET tracer LBT-999: from conception to clinical use Front Med 6 1480-682